Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 1.14 M913 K1.2 M920 K 4.18 M Research & development ———— — Operating income 3.19 M-62.8 M-8.55 M-16.83 M -84.99 M Non-Operating Income, Total -18.53 M-55.51 M-33.76 M-39.88 M -147.68 M Interest expense, net of interest capitalized 8.5 M9.63 M9.49 M9.52 M 37.14 M Non-Operating Income, excl. Interest Expenses -27.03 M-65.14 M-43.25 M-49.4 M -184.82 M Unusual income/expense ———— — Pretax income 5.53 M-59.96 M-5.71 M-13.64 M -73.78 M Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 7.77 M28.71 M65.9 M82.37 M 184.75 M Discontinued operations ———— — Net income 7.77 M28.71 M65.9 M82.37 M 184.75 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 7.77 M28.71 M65.9 M82.37 M 184.75 M Basic earnings per share (Basic EPS) 0.210.751.662.15 4.77 Diluted earnings per share (Diluted EPS) 0.210.751.662.13 4.75 Average basic shares outstanding 36.91 M38.45 M39.68 M38.71 M — Diluted shares outstanding 36.91 M38.45 M39.68 M38.71 M — EBITDA -4.4 M-71.52 M-17.07 M-25.26 M -118.25 M EBIT -5.31 M-72.43 M-18.04 M-26.34 M -122.13 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 910 K910 K972 K1.09 M 3.88 M